LTCR‑N1‑1
EBV‑related nasopharyngeal carcinoma
Pre‑clinicalUpcoming
Key Facts
About Lion TCR
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profileEBV‑related nasopharyngeal carcinoma
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profile